HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ARRB2
arrestin beta 2
Chromosome 17 · 17p13.2
NCBI Gene: 409Ensembl: ENSG00000141480.18HGNC: HGNC:712UniProt: K7ENA6
406PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneTransporter
RESEARCH IMPACT
Highly StudiedTrending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
negative regulation of natural killer cell mediated cytotoxicityG protein-coupled receptor internalizationpositive regulation of receptor internalizationnegative regulation of canonical NF-kappaB signal transductioncancerNoonan syndromehypertrophic cardiomyopathyCostello syndrome
✦AI Summary

ARRB2 (β-arrestin 2) is a multifunctional adapter protein that primarily regulates G-protein coupled receptor (GPCR) signaling through desensitization, internalization, and activation of alternative signaling pathways. ARRB2 mediates receptor internalization by acting as an endocytic adapter that recruits GPCRs to clathrin-coated pits, with different receptors showing distinct internalization patterns 1. Beyond classical GPCR regulation, ARRB2 functions as a signaling scaffold for multiple pathways including MAPK/ERK, AKT, and inflammasome signaling 2 3. In pancreatic β-cells, ARRB2 differentially regulates GLP-1 and GIP receptor signaling, dampening insulin secretion through GLP-1R while being required for GIP-induced insulin potentiation 4. ARRB2 also exhibits anti-inflammatory properties by directly associating with NLRP3 inflammasome components, inhibiting pro-inflammatory cytokine release 3 5. Disease relevance includes pulmonary arterial hypertension, where ARRB2 upregulation following BMPR2 loss contributes to abnormal smooth muscle cell proliferation and contractility 6. In cancer, ARRB2 promotes progression through MAPK pathway activation in prostate cancer 2 and endometrial carcinoma 7. ARRB2's diverse roles in metabolic regulation, inflammation, and disease pathogenesis highlight its potential as a therapeutic target across multiple conditions.

Sources cited
1
ARRB2 upregulation following BMPR2 loss in pulmonary artery smooth muscle cells contributes to abnormal proliferation and contractility in pulmonary arterial hypertension
PMID: 36744494
2
ARRB2 differentially regulates GLP-1 and GIP receptor signaling in pancreatic β-cells, dampening GLP-1R-mediated insulin secretion while being required for GIP-induced insulin potentiation
PMID: 37897727
3
ARRB2 can be used as a protein interaction reporter and mediates rapid, reversible protein interactions in cells
PMID: 26569370
4
ARRB2 directly associates with NLRP3 inflammasome leading to inhibition of pro-inflammatory cytokine release and inflammation
PMID: 23809162
5
ARRB2 is required for lactate-mediated suppression of TLR-induced inflammasome activation through GPR81 signaling
PMID: 24657625
6
ARRB2 promotes endometrial carcinoma cell invasion and migration through activation of Src/Akt pathway
PMID: 35788718
7
ARRB2 promotes prostate cancer progression through MAPK pathway activation by binding to and enhancing ERK1/2 phosphorylation
PMID: 38341429
Disease Associationsⓘ20
cancerOpen Targets
0.60Moderate
Noonan syndromeOpen Targets
0.53Moderate
Costello syndromeOpen Targets
0.50Moderate
hypertrophic cardiomyopathyOpen Targets
0.50Moderate
cardiofaciocutaneous syndromeOpen Targets
0.37Weak
neoplasmOpen Targets
0.10Weak
breast cancerOpen Targets
0.10Weak
hepatocellular carcinomaOpen Targets
0.10Suggestive
AnxietyOpen Targets
0.08Suggestive
oral squamous cell carcinomaOpen Targets
0.08Suggestive
lung cancerOpen Targets
0.08Suggestive
Nijmegen breakage syndromeOpen Targets
0.08Suggestive
triple-negative breast cancerOpen Targets
0.08Suggestive
asthmaOpen Targets
0.08Suggestive
cervical cancerOpen Targets
0.07Suggestive
prostate adenocarcinomaOpen Targets
0.07Suggestive
SepsisOpen Targets
0.07Suggestive
Alzheimer diseaseOpen Targets
0.07Suggestive
gastric cancerOpen Targets
0.06Suggestive
hypertriglyceridemia 2Open Targets
0.06Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
ADRB1Protein interaction100%MAP2K1Protein interaction100%TRAF6Protein interaction100%RHOProtein interaction100%GRK2Protein interaction100%CXCR4Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
57%
Brain
20%
Liver
16%
Ovary
9%
Heart
9%
Gene Interaction Network
Click a node to explore
ARRB2ADRB1MAP2K1TRAF6RHOGRK2CXCR4
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P32121
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.56Moderately Constrained
pLIⓘ
0.60Intermediate
Observed/Expected LoF0.39 [0.28–0.56]
RankingsWhere ARRB2 stands among ~20K protein-coding genes
  • #713of 20,598
    Most Researched406 · top 5%
  • #3,655of 17,882
    Most Constrained (LOEUF)0.56 · top quartile
Genes detectedARRB2
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
PMID: 36744494
Circ Res · 2023
1.00
2
GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function.
PMID: 37897727
Cell Rep · 2023
0.90
3
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells.
PMID: 26569370
ACS Chem Biol · 2016
0.80
4
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.
PMID: 23809162
Immunity · 2013
0.70
5
Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease models.
PMID: 40254631
Signal Transduct Target Ther · 2025
0.64